Ventyx Biosciences : Cash, Cash Equivalents and Marketable Securities as of June 30, Expected to Fund Planned Operations Into at Least 2H of 2026
Ventyx生物科技:截至6月30日的現金、現金等價物和可市場交易證券預計將支持計劃中的運營至少持續到2026年下半年。
Ventyx Biosciences : Cash, Cash Equivalents and Marketable Securities as of June 30, Expected to Fund Planned Operations Into at Least 2H of 2026
Ventyx生物科技:截至6月30日的現金、現金等價物和可市場交易證券預計將支持計劃中的運營至少持續到2026年下半年。
譯文內容由第三人軟體翻譯。